Our observations for RCC TiNK are consistent with findings that a CD56+CD16neg subset of NK dominates in NSCLC tumors acting as proangiogenic cells by producing VEGF and PGF [26]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.